ストックスクリーナーアプリを入手
25.86
1.46%
0.48
前日終値:
$25.38
開ける：
$25.55
24時間の取引高:
16.57M
Relative Volume:
0.50
時価総額：
$5.98B
収益：
$2.35B
当期純損益:
$128.37M
株価収益率:
49.53
EPS:
0.5221
ネットキャッシュフロー:
$57.42M
1週間 パフォーマンス:
+8.42%
1か月 パフォーマンス:
-2.20%
6か月 パフォーマンス:
-35.24%
1年 パフォーマンス:
-50.86%
1日の値動き範囲:
$24.13
$26.64
1週間の範囲:
$23.36
$26.64
52週間の値動き範囲:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Compare HIMS vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
25.85 | 5.87B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
15.97 | 51.03B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.70 | 40.20B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.085 | 40.78B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
77.66 | 32.81B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
551.04 | 23.86B | 3.17B | 1.29B | 1.01B | 27.09 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-24 | 開始されました | JP Morgan | Overweight |
| 2026-03-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-03-10 | アップグレード | Citigroup | Sell → Neutral |
| 2026-03-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Hims And Hers Canadian GLP 1 Push Tests Broader Wellness Subscription Thesis - Yahoo Finance
Flo Health Expands Distribution Through Collaboration With Hims & Hers Benefits - TipRanks
HIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform - TradingView
Hims & Hers adds eight partners to subscriber benefits program By Investing.com - Investing.com Australia
PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today - TradingKey
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners - Business Wire
HIMS Stock Heads For Weekly Loss — But Ex-Netflix CFO Is Buying The Dip Despite BofA’s GLP-1 Warning - Stocktwits
Hims & Hers Health Expands Benefits Program With Eight New Partners - TradingView
One Subscription. Ten Ways to Feel Your Best. - Hims & Hers Newsroom
Hims & Hers Debt-Funded Expansion Tests Its Global Telehealth Ambitions - Investing.com
Hims & Hers eyes global growth: Will $1.15B Eucalyptus deal fuel its recovery or dilute shareholders? - MSN
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? - MarketBeat
HIMS stock slips overnight: Hims & Hers bulks up debt raise to $350M for Eucalyptus buyout, AI push - MSN
Hims & Hers Health Inc (HIMS) Shares Surge 5.7% -- What GF Score of 77 Tells Investors - GuruFocus
Hims & Hers Gains 5% on Insider Buying - TradingView
Hims & Hers Health (HIMS) Jumps 7.1% to $25.54 - AlphaStreet
Hims & Hers stock rises after insider buy (HIMS:NYSE) - Seeking Alpha
Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot - Barron's
HIMS vs. TEM: Which AI Healthcare Stock Offers Better Upside Now? - Zacks Investment Research
Hims & Hers Shares Rally On Million-Dollar Insider Purchase - Benzinga
Why is Hims & Hers Health stock rallying today? By Investing.com - Investing.com Canada
Can Hims & Hers (HIMS) Canadian GLP-1 Push Redefine Its Long-Term Profitability Playbook? - simplywall.st
HIMS stock heads for weekly loss — but ex-Netflix CFO is buying the dip despite BofA’s GLP-1 warning - MSN
Here is what to know beyond why Hims & Hers Health, Inc. (HIMS) is a trending stock - MSN
Hims & Hers Health stock rises as director buys shares By Investing.com - Investing.com Canada
Hims & Hers Health stock rises as director buys shares - Investing.com
Hims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofA - Proactive financial news
HIMS stock extends 3-day rally: Hims & Hers targets GLP-1 gold rush in Canada after Novo Nordisk patent expiry - MSN
Hims & Hers Health, Inc. Stock 12‑Month Price Target Cut to $27.71, Implies 17% Upside - TradingView
Hims & Hers Stock Jumped 6.6% This Week. Here’s What a $350 Million Capital Raise for Growth - TIKR.com
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $25 - Moomoo
BofA cuts Hims and Hers stock price target on GLP-1 ramp concerns - Investing.com Canada
Modest pullback for Hims & Hers Health stock as oversold signals emerge - Traders Union
HIMS Stock Price, Quote & Chart | HIMS & HERS HEALTH INC (NYSE:HIMS) - ChartMill
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Four telehealth platforms now offer generic semaglutide - Benefits and Pensions Monitor
Hims & Hers Health stock price forecast: $22.50 support as HIMS trades down - Traders Union
(HIMS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
How The Hims & Hers Health (HIMS) Story Is Shifting With GLP‑1 Hopes And Margin Questions - Yahoo Finance
Hims & Hers Health (HIMS) Stock Forum and Discussion - Moomoo
Hims & Hers Health Inc. Class A (HIMS) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Hims & Hers Health Options Spot-On: On May 22nd, 109.56K Contracts Were Traded, With 1.05 Million Open Interest - Moomoo
Hims & Hers (HIMS) CMO-director gets 435 RSUs instead of $10K cash retainer - Stock Titan
Hims & Hers (HIMS) director Christopher Payne awarded 647 RSUs for Q1 2026 fees - Stock Titan
Hims & Hers Health (HIMS) director awarded 957 RSUs for Q1 fees - Stock Titan
Latham Advises on Hims & Hers Health, Inc.’s Upsized US$350 Million Convertible Senior Notes Offering - Latham & Watkins LLP
HIMS Maintained by Truist Securities -- Price Target Raised to $23 - GuruFocus
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
0.44%
0.37%
大文字化:
|
ボリューム (24 時間):